| scholarly article | Q13442814 |
| P2093 | author name string | K. G. Peters | |
| M. G. Kienzle | |||
| P2860 | cites work | Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction | Q34051232 |
| Tachycardia induced myocardial dysfunction. A reversible phenomenon? | Q36756347 | ||
| Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects | Q40172905 | ||
| Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy | Q42229679 | ||
| Amiodarone for refractory atrial fibrillation | Q69992187 | ||
| Measurement of ventricular function by ECG gating during atrial fibrillation | Q70691079 | ||
| Effect of amiodarone on ventricular function as measured by gated radionuclide angiography | Q70696132 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Atrial Fibrillation | Q815819 |
| cardiomyopathy | Q847583 | ||
| P304 | page(s) | 242-244 | |
| P577 | publication date | 1988-08-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm | |
| P478 | volume | 85 |
| Q22306346 | 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration |
| Q34530208 | A review of atrial fibrillation |
| Q41731235 | Acute treatment of atrial fibrillation: why and when to maintain sinus rhythm |
| Q74011185 | Alterations in myocardial free fatty acid clearance precede mechanical abnormalities in canine tachycardia-induced heart failure |
| Q41948308 | Antiarrhythmic drugs in the management of atrial fibrillation |
| Q73742703 | Atrial fibrillation |
| Q42390387 | Atrial fibrillation begets trouble |
| Q35096835 | Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy |
| Q33545473 | Atrial fibrillation in the elderly |
| Q34183370 | Atrial fibrillation pearls and perils of management |
| Q40973875 | Atrial fibrillation: maintenance of sinus rhythm versus rate control |
| Q37855664 | Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome |
| Q74523241 | Biatrial pacing for paroxysmal atrial fibrillation: a randomized prospective study into the suppression of paroxysmal atrial fibrillation using biatrial pacing |
| Q77295591 | Cardiac performance early after cardioversion from atrial fibrillation |
| Q43693066 | Catheter ablation for atrial fibrillation results in greater improvement in cardiac function in patients with low versus normal left ventricular ejection fraction |
| Q33640696 | Chronic and paroxysmal atrial fibrillation: course, prognosis, and stroke risk |
| Q33145671 | Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management |
| Q37319849 | Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter |
| Q37729895 | Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study |
| Q42226118 | Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker? |
| Q44432066 | Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy |
| Q71975697 | Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation |
| Q41428731 | Long-term management of atrial fibrillation. |
| Q41089651 | Maintaining sinus rhythm with antifibrillatory drugs in atrial fibrillation |
| Q43760387 | Mitral regurgitation recovery and atrial reverse remodeling following pulmonary vein isolation procedure in patients with atrial fibrillation: a clinical observation proof-of-concept cardiac MRI study |
| Q35680137 | Pharmacological rate control of atrial fibrillation |
| Q37226141 | Pharmacological treatment of atrial fibrillation: a review on prevention of recurrences and control of ventricular response. |
| Q43240016 | Prevalence, clinical correlates and treatment of permanent atrial fibrillation among the elderly: insights from the first prospective population-based study in rural Greece |
| Q35120874 | Prevention and management of chronic heart failure with electrical therapy |
| Q34821575 | Prevention of and medical therapy for atrial arrhythmias in heart failure. |
| Q73352643 | Prevention of short term reversible chronic atrial fibrillation by permanent pacing at the triangle of Koch |
| Q35166383 | Rate control in atrial fibrillation: choice of treatment and assessment of efficacy |
| Q77535826 | Rate issues in atrial fibrillation: consequences of tachycardia and therapy for rate control |
| Q74787770 | Resolution of cardiomyopathy after ablation of atrial flutter |
| Q36108848 | Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities |
| Q73975512 | Tachycardia cardiomyopathy |
| Q42718115 | Tachycardia-induced Cardiomyopathy (Tachycardiomyopathy). |
| Q41416463 | Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies |
| Q42119812 | Tachycardia-induced heart failure. |
| Q73379220 | Tachycardia-induced primate model of heart failure in cardiovascular drug discovery |
| Q64074292 | The Evolving Role of Catheter Ablation in Patients With Heart Failure and AF |
| Q41664554 | The medical management of atrial fibrillation. |
| Q36861173 | The role of heart rate in the development of cardiovascular disease |
| Q41352642 | The treatment of atrial fibrillation: pharmacologic and nonpharmacologic strategies |
| Q33175666 | The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide |
| Q77468071 | Unexpected instant death following successful coronary artery bypass graft surgery (and other clinical settings): atrial fibrillation, quinidine, procainamide, et cetera, and instant death |
| Q79459564 | [Incidents of cutaneous alteration secondary to external electrical cardioversion] |
| Q74622550 | [New concepts on the treatment of atrial fibrillation] |
Search more.